← back to search

Johnny Amer

An-Najah National University · US
Area of research
Epidemiology · Genetics
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Hemoglobinopathies and Related Disorders, Immune Cell Function and Interaction, and Liver physiology and pathology.
h-index
25
citations
2,265
works
156
NIH funding
primary concept
Medicine
email

Recent publications

Rosuvastatin restores liver tissue-resident NK cell activation in aged mice by improving mitochondrial function
Biomedicine & Pharmacotherapy 2025cited by 5position: firstdoi
High-fat diet mouse model receiving L-glucose supplementations propagates liver injury
Frontiers in Nutrition 2024cited by 2position: firstdoi
CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis
JCI Insight 2023cited by 40position: middledoi
Alleviation of Hepatic Steatosis by Alpha-Defensin Is Associated with Enhanced Lipolysis
Medicina 2023cited by 4position: middledoi
Advanced Liver Fibrosis Correlates With Impaired Efficacy of Pfizer‐BioNTech COVID‐19 Vaccine in Medical Employees
Hepatology Communications 2022cited by 7position: middledoi
Sodium <sup>+</sup> /taurocholate cotransporting polypeptide as target therapy for liver fibrosis
Gut 2021cited by 57position: middledoi
Efficacy of Birth Dose Vaccination in Preventing Mother-to-Child Transmission of Hepatitis B: A Randomized Controlled Trial Comparing Engerix-B and Sci-B-Vac
Vaccines 2021cited by 12position: middledoi
Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122
Gastroenterology 2020cited by 87position: middledoi
25(OH) D3 alleviate liver NK cytotoxicity in acute but not in chronic fibrosis model of BALB/c mice due to modulations in vitamin D receptor
BMC Gastroenterology 2020cited by 10position: middledoi
The direct profibrotic and indirect immune antifibrotic balance of blocking the cannabinoid 2 receptor
American Journal of Physiology-Gastrointestinal and Liver Physiology 2012cited by 9position: middledoi
Triphala (PADMA) extract alleviates bronchial hyperreactivity in a mouse model through liver and spleen immune modulation and increased anti-oxidative effects
Therapeutic Advances in Respiratory Disease 2012cited by 6position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Rifaat Safadi · Hadassah Medical Center10 papers (2012–2025)Ahmad Salhab · An-Najah National University4 papers (2020–2024)Yinying Lu · Fujian Medical University2 papers (2020–2021)S. Doron · Hebrew University of Jerusalem2 papers (2012–2012)Mahmud Mahamid · Hebrew University of Jerusalem2 papers (2012–2021) · 1 papers (2021–2021)Rufayda Mruwat · Hebrew University of Jerusalem1 papers (2012–2012)Amjad Horani · Hebrew University of Jerusalem1 papers (2012–2012)Rami Abu‐Fanne · Technion – Israel Institute of Technology1 papers (2023–2023) · 1 papers (2023–2023) · 1 papers (2021–2021)Yael Milgrom · Hebrew University of Jerusalem1 papers (2022–2022)Shira Yochelis · Hebrew University of Jerusalem1 papers (2024–2024) · 1 papers (2023–2023)Elliot M. Berry · Hebrew University of Jerusalem1 papers (2012–2012)Yossi Paltiel · Hebrew University of Jerusalem1 papers (2024–2024) · 1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2023–2023)